Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa Crawford(Queen's University Belfast), Alexandra E. Irvine(Université Paris Cité)OncotargetSeptember 15, 201610.18632/oncotarget.12026Cited by 27SaveCiteExport RISWatch citationsRelated PapersA novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation|Blood|2006|67Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models|Oncogenesis|2014|26